Prostatic preneoplasia and beyond.

Prostatic preneoplasia and beyond.

Item
http://www.wikidata.org/entity/Q37047894
Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targetsTelomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanomaThe identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancerSubcellular localization of p44/WDR77 determines proliferation and differentiation of prostate epithelial cellsMolecular marks for epigenetic identification of developmental and cancer stem cellsPolyphenols from the Mediterranean herb rosemary (Rosmarinus officinalis) for prostate cancer.Organ-wide telomeric status in diseased and disease-free prostatic tissues.Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines.Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer.
P2860

Prostatic preneoplasia and beyond.

Item
http://www.wikidata.org/entity/Q37047894
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostatic preneoplasia and beyond.
@en
Prostatic preneoplasia and beyond.
@nl
type
label
Prostatic preneoplasia and beyond.
@en
Prostatic preneoplasia and beyond.
@nl
prefLabel
Prostatic preneoplasia and beyond.
@en
Prostatic preneoplasia and beyond.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Prostatic preneoplasia and beyond.
@en
P2093
P304
P31
P356
10.1016/J.BBCAN.2007.12.001
P407
P433
P478
P577
P5875
P698